PubRank

Robert S Sandler

Author PubWeight™ 296.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005 15.46
2 A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003 9.18
3 Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007 7.93
4 Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012 7.15
5 Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004 7.02
6 Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005 4.31
7 Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008 3.79
8 Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003 3.44
9 Clinical practice. Screening for colorectal cancer. N Engl J Med 2002 3.43
10 A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006 3.35
11 Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol 2013 3.31
12 Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009 3.15
13 A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology 2011 3.03
14 Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007 2.94
15 The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006 2.93
16 A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med 2015 2.88
17 Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 2008 2.83
18 Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2010 2.80
19 A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gastroenterol 2002 2.75
20 Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010 2.70
21 Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009 2.64
22 A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet 2011 2.43
23 RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest 2007 2.25
24 Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis 2012 2.23
25 KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Mol Cancer Ther 2009 2.22
26 Digestive and liver diseases statistics, 2004. Gastroenterology 2004 2.14
27 A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am J Gastroenterol 2009 2.14
28 Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008 2.13
29 Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol 2010 2.10
30 Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol 2003 2.06
31 Fusobacterium is associated with colorectal adenomas. PLoS One 2013 1.99
32 Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012 1.97
33 Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol 2013 1.83
34 Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst 2003 1.80
35 Patient time requirements for screening colonoscopy. Am J Gastroenterol 2007 1.74
36 Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007 1.73
37 Editorial: colonoscopy and colorectal cancer mortality: strong beliefs or strong facts? Am J Gastroenterol 2010 1.71
38 Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol 2013 1.71
39 Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol 2008 1.71
40 Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011 1.70
41 Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003 1.70
42 Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 2004 1.70
43 Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci 2010 1.68
44 Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 2004 1.67
45 Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol 2011 1.66
46 Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 2012 1.62
47 Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005 1.52
48 Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl 2002 1.52
49 Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol 2005 1.49
50 Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002 1.48
51 Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg 2010 1.48
52 Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol 2016 1.47
53 Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2005 1.45
54 Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study. Med Decis Making 2008 1.45
55 Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev 2004 1.45
56 Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health 2006 1.37
57 Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care 2013 1.36
58 Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis 2011 1.33
59 Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev 2005 1.31
60 Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology 2010 1.31
61 Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2003 1.29
62 Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 2012 1.27
63 Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer 2006 1.22
64 Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol 2011 1.21
65 Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology 2006 1.21
66 Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology 2002 1.20
67 Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis 2011 1.17
68 Rural-urban differences in colon cancer risk in blacks and whites: the North Carolina Colon Cancer Study. J Rural Health 2006 1.16
69 Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol 2003 1.16
70 Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007 1.16
71 Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res 2010 1.15
72 Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 2005 1.13
73 Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol 2006 1.13
74 A diet high in fruits and low in meats reduces the risk of colorectal adenomas. J Nutr 2007 1.11
75 Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst 2006 1.11
76 Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer 2004 1.11
77 Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2002 1.10
78 Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis 2008 1.10
79 The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev 2009 1.10
80 Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol 2008 1.06
81 Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev 2010 1.06
82 Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans. Cancer Epidemiol Biomarkers Prev 2009 1.05
83 Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 2007 1.05
84 UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat Res 2008 1.05
85 Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol 2010 1.05
86 Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst 2009 1.05
87 Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf 2013 1.05
88 Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev 2008 1.05
89 Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005 1.04
90 The association of physical activity and body mass index with the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 2005 1.04
91 Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners). Inflamm Bowel Dis 2014 1.03
92 Quality of colonoscopy reporting: a process of care study. Am J Gastroenterol 2002 1.03
93 Gastrointestinal endoscopy nurse experience and polyp detection during screening colonoscopy. Clin Gastroenterol Hepatol 2008 1.03
94 Patient perspectives on research recruitment through cancer registries. Cancer Causes Control 2005 1.02
95 Race and colorectal cancer screening: a population-based study in North Carolina. N C Med J 2004 1.02
96 Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control 2012 1.02
97 COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States). Cancer Causes Control 2006 1.01
98 Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol 2013 1.00
99 Health behavior correlates among colon cancer survivors: NC STRIDES baseline results. Am J Health Behav 2006 1.00
100 A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev 2014 0.99
101 Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs. Cancer 2002 0.98
102 Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer Study. Nutr Cancer 2009 0.98
103 Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol 2006 0.98
104 Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol 2004 0.98
105 Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer 2011 0.97
106 The effect of hospital and surgeon volume on outcomes for rectal cancer surgery. Clin Gastroenterol Hepatol 2008 0.97
107 Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res 2007 0.96
108 Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol 2003 0.96
109 Family history of colon cancer: what does it mean and how is it useful? Am J Prev Med 2003 0.96
110 Hospital-to-hospital variation in lymph node detection after colorectal resection. Cancer 2004 0.95
111 Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control 2006 0.95
112 Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis 2014 0.95
113 Studying genetic research participants: lessons from the "Learning About Research in North Carolina" study. Cancer Epidemiol Biomarkers Prev 2008 0.95
114 Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 2007 0.95
115 Impact of functional support on health-related quality of life in patients with colorectal cancer. Cancer 2004 0.94
116 Patient perception of chronic illness care in a large inflammatory bowel disease cohort. Inflamm Bowel Dis 2013 0.94
117 Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev 2008 0.94
118 Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 2014 0.93
119 Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst 2009 0.92
120 Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2009 0.92
121 Does physical activity modify the association between body mass index and colorectal adenomas? Nutr Cancer 2005 0.92
122 Fine-mapping of genome-wide association study-identified risk loci for colorectal cancer in African Americans. Hum Mol Genet 2013 0.92
123 Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am J Epidemiol 2005 0.92
124 Surgeons' volume of colorectal cancer procedures and collaborative decision-making about adjuvant therapies. Ann Surg 2009 0.92
125 Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 2009 0.92
126 Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Arch Dis Child 2011 0.91
127 Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data. Inflamm Bowel Dis 2011 0.91
128 GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control 2006 0.90
129 Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007 0.90
130 Selenium, folate, and colon cancer. Nutr Cancer 2009 0.90
131 Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev 2005 0.90
132 Estimating the cost of no-shows and evaluating the effects of mitigation strategies. Med Decis Making 2013 0.89
133 Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage. Am J Gastroenterol 2003 0.89
134 Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas. BMC Cancer 2008 0.89
135 Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol 2005 0.88
136 Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome. PLoS One 2012 0.88
137 Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control 2014 0.87
138 Site organization and management. Inflamm Bowel Dis 2005 0.87
139 Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas. Cancer Epidemiol Biomarkers Prev 2008 0.87
140 Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J Proteome Res 2014 0.87
141 Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans. Am J Epidemiol 2008 0.86
142 Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005 0.86
143 Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases. Am J Gastroenterol 2009 0.86
144 Perceptions of patients with inflammatory bowel diseases on biobanking. Inflamm Bowel Dis 2015 0.86
145 Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. J Nutrigenet Nutrigenomics 2008 0.86
146 Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis 2013 0.86
147 Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2014 0.86
148 Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control 2015 0.86
149 Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population. J Clin Gastroenterol 2013 0.85
150 Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol 2008 0.85
151 Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. Am J Gastroenterol 2002 0.85
152 Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients. Cancer 2013 0.85
153 Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes 2012 0.84
154 Roles of religious involvement and social support in the risk of colon cancer among Blacks and Whites. Am J Epidemiol 2003 0.84
155 Associations of red meat, fat, and protein intake with distal colorectal cancer risk. Nutr Cancer 2010 0.84
156 Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2006 0.84
157 The effect of early life antibiotic exposures on diarrheal rates among young children in Vellore, India. Pediatr Infect Dis J 2015 0.84
158 Inhibition of fried meat-induced colorectal DNA damage and altered systemic genotoxicity in humans by crucifera, chlorophyllin, and yogurt. PLoS One 2011 0.83
159 Assessment of serum proteomics to detect large colon adenomas. Cancer Epidemiol Biomarkers Prev 2008 0.83
160 Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study. Am J Gastroenterol 2010 0.83
161 Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005 0.83
162 Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians. PLoS One 2011 0.83
163 Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis 2014 0.83
164 Positive and negative predictive values: use of inflammatory bowel disease serologic markers. Am J Gastroenterol 2006 0.83
165 Inverse relationship between moderate alcohol intake and rectal cancer: analysis of the North Carolina Colon Cancer Study. Dis Colon Rectum 2011 0.83
166 The effect of physician permission versus notification on research recruitment through cancer registries (United States). Cancer Causes Control 2006 0.82
167 Associations between trans fatty acid consumption and colon cancer among Whites and African Americans in the North Carolina colon cancer study I. Nutr Cancer 2009 0.82
168 Association of health beliefs and colonoscopy use among survivors of colorectal cancer. J Cancer Surviv 2009 0.82
169 A critical evaluation of serologic markers for inflammatory bowel disease. Clin Gastroenterol Hepatol 2007 0.82
170 Resource utilization associated with irritable bowel syndrome in the United States 1987-1997. Dig Dis Sci 2002 0.81
171 Vitamin C intake and apoptosis in normal rectal epithelium. Cancer Epidemiol Biomarkers Prev 2003 0.81
172 Eating frequency and colon cancer risk. Nutr Cancer 2004 0.81
173 Moderate alcohol consumption protects against colorectal adenomas in smokers. Dig Dis Sci 2007 0.80
174 Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2013 0.80
175 Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa. BMC Cancer 2012 0.80
176 Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study. Cancer Epidemiol Biomarkers Prev 2013 0.80
177 Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures. Inflamm Bowel Dis 2016 0.80
178 Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention. Cancer Prev Res (Phila) 2011 0.79
179 IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites. Dis Markers 2012 0.79
180 Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer. Cancer Causes Control 2010 0.79
181 Cholecystectomy and the risk of recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007 0.79
182 Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016 0.78
183 Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions. Gastroenterology 2009 0.78
184 Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease. Inflamm Bowel Dis 2013 0.78
185 Tea intake and risk of colon cancer in African-Americans and whites: North Carolina colon cancer study. Cancer Causes Control 2003 0.78
186 Aspirin prevention of colorectal cancer: more or less? Ann Intern Med 2004 0.78
187 Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis 2015 0.77
188 CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control 2012 0.77
189 trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II. Cancer Causes Control 2009 0.77
190 Cholecystectomy and the risk of colorectal adenomas. Dig Dis Sci 2007 0.77
191 Risk factors for advanced disease in colorectal cancer. Am J Gastroenterol 2004 0.77
192 Diverticular disease: reconsidering conventional wisdom. Clin Gastroenterol Hepatol 2013 0.77
193 Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 2010 0.76
194 Variability in resource use: diagnosing colorectal cancer. Am J Manag Care 2013 0.76
195 Calcium supplements to prevent colorectal adenomas. Am J Gastroenterol 2005 0.76
196 Racial differences in obesity measures and risk of colorectal adenomas in a large screening population. Nutr Cancer 2014 0.76
197 Quality of colon carcinoma pathology reporting: a process of care study. Cancer 2004 0.76
198 Risk of colorectal cancer after initiation of orlistat: matched cohort study. BMJ 2013 0.76
199 Bone health in a tertiary-care gastroenterology and hepatology population. Dig Dis Sci 2010 0.75
200 Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease. J Med Internet Res 2016 0.75
201 Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset. Inflamm Bowel Dis 2017 0.75
202 The right test for colon cancer screening? Gastrointest Endosc 2006 0.75
203 Realistic expectations after negative colonoscopy. Clin Gastroenterol Hepatol 2008 0.75
204 Effect of GI endoscopy nurse experience on screening colonoscopy outcomes. Gastrointest Endosc 2009 0.75
205 Serum salicylate levels and risk of recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2011 0.75
206 Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis. Inflamm Bowel Dis 2016 0.75
207 Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers. Inflamm Bowel Dis 2016 0.75
208 Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk. BMC Res Notes 2010 0.75
209 Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. Epidemiology 2015 0.75
210 Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study. JMIR Res Protoc 2016 0.75
211 Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer. Prostaglandins Other Lipid Mediat 2011 0.75
212 The Impact of Ostomy on Quality of Life and Functional Status of Crohn's Disease Patients. Inflamm Bowel Dis 2016 0.75
213 Colonoscopy: virtual, optical, or chromoscopic? Gastroenterology 2004 0.75
214 Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis. Inflamm Bowel Dis 2017 0.75
215 Cybermedicine and the gastroenterologist. Gastroenterology 2006 0.75
216 Quality of care in gastroenterology: beyond the bell curve. Gastroenterology 2005 0.75
217 Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners. Inflamm Bowel Dis 2017 0.75